<DOC>
	<DOC>NCT02877407</DOC>
	<brief_summary>- objective: aimed to compare laparoscopic/robot-assisted hysteropexy with vaginal hysterectomy for uterine prolapse - prospective randomized clinical trial - patient 1. 60yrs or more women and 2. POP-Q stage II with symptom or POP-Q III, IV regardless of symptom - number of patient: 146 - randomize: laparoscopic/robot-assisted hysteropexy vs. hysterectomy - follow up: postoperative 1 year - primary endpoint: recurrence rate 1. recurrence of uterovaginal prolapse POP-Q stage II-IV 2. recurrence of associated symptom - secondary endpoint 1. postoperative 1 year QOL, degree of satisfaction evaluation 2. operative time, estimated blood loss 3. hospitalization period, postoperative pain, return to normal activity</brief_summary>
	<brief_title>Laparoscopic/Robotic-assisted Hysteropexy Versus Vaginal Hysterectomy for the Treatment of Uterovaginal Prolapse</brief_title>
	<detailed_description />
	<mesh_term>Prolapse</mesh_term>
	<criteria>POPQ stage II with symptom or POPQ III, IV regardless of symptom abnormal uterine bleeding significantly enlarged fibroid uterus postmenopausal uterine bleeding endometrial pathology on tamexifen concomitant medical problems precluding general anesthesia or surgery damaged agreement ability</criteria>
	<gender>Female</gender>
	<minimum_age>60 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2016</verification_date>
</DOC>